|
The Non-Hodgkin’s Lymphoma Drug Market Will Nearly Double to More Than …
The Providence Journal The Pharmacor advisory service entitled Non-Hodgkin’s Lymphoma finds that sales of rituximab dominate the current market, and will continue to do so through 2022, regardless of biosimilar rituximab entry. Teva Pharmaceutical Industries’ … |
Lung cancer: Early palliative care can lead to improvements in quality of life … – myfox8.com
Lung cancer: Early palliative care can lead to improvements in quality of life …myfox8.comDr. Ramaswamy is a 1995 graduate of Coimbatore Medical College in Tamil Nadu, India. He completed his residency in internal medicine at MetroHealth Medical Cent…
13-year-old recovery nicely after kidney transplant – Waterloo Record
|
13-year-old recovery nicely after kidney transplant
Waterloo Record When that call finally came, Phil and Sandi took Tyrel to Toronto’s Hospital for Sick Children where he had the transplant surgery. “The kidney was a perfect match and he did well for the first few days,” Sandi said. “Then we had a scare. He developed … |
The Non-Hodgkin's Lymphoma Drug Market Will Nearly Double to More Than … – Sacramento Bee
|
The Non-Hodgkin’s Lymphoma Drug Market Will Nearly Double to More Than …
Sacramento Bee The Pharmacor advisory service entitled Non-Hodgkin’s Lymphoma finds that sales of rituximab dominate the current market, and will continue to do so through 2022, regardless of biosimilar rituximab entry. Teva Pharmaceutical Industries’ … |
New Findings Published In Circulation: Heart Failure Show Potential Utility Of … – PR Newswire (press release)
New Findings Published In Circulation: Heart Failure Show Potential Utility Of …PR Newswire (press release)CHAPEL HILL, N.C., Oct. 28, 2013 /PRNewswire/ — Cardioxyl Pharmaceuticals, Inc. announced today the publication of recent findings on the role…
Accelerated growth for AbbVie's Humira lifts 3rd-quarter results above expectation – The Pharma Letter
|
Accelerated growth for AbbVie’s Humira lifts 3rd-quarter results above expectation
The Pharma Letter AbbVie’s partnership with Biogen Idec (Nasdaq: BIIB) on daclizumab also looks promising. The drug targets treatment of patients with relapsed or remitting multiple sclerosis. Daclizumab is currently in a late-stage study. AbbVie and Biogen expect that … |
Lou Reed: Rock 'N' roll poet of the streets – India Today
Times of India |
Lou Reed: Rock ‘N’ roll poet of the streets
India Today Yes, Reed, who died Sunday at age 71 of liver disease related to a recent transplant, wasn’t an easy man. New York isn’t an easy town. Few artists reflected a city better than he did, and he found it an endless source of inspiration. The 2003 … Musician Lou Reed deadTimes of India Rocker Lou Reed of Velvet Underground dies at 71Daily News & Analysis Rock legend Lou Reed dies at 71Newstrack India Yahoo India News all 1,524 news articles » |
Legendary rock singer Lou Reed dies at age 71 – KERO-TV 23
KERO-TV 23Legendary rock singer Lou Reed dies at age 71KERO-TV 23Reed continued to release new albums and tour during his four-decade solo career, performing in front of audiences until a just a few weeks before his transplant surgery. Reed was schedul…
Rituximab drug may be safe, effective for immunoglobulin G4-related disease … – News-Medical.net
|
Rituximab drug may be safe, effective for immunoglobulin G4-related disease …
News-Medical.net Rituximab (Rituxan®) — a drug commonly used rheumatoid arthritis, granulomatosis with polyangiitis (formerly Wegener’s), and certain types of cancers — may be a safe and effective treatment for immunoglobulin G4-related disease (commonly called … |
Venezuela creates official happiness agency – Omaha World-Herald
|
Venezuela creates official happiness agency
Omaha World-Herald BROWNSBURG, Ind. — A central Indiana woman who promised to donate one of her kidneys to a man she barely knew has married him three years after his successful transplant surgery. Chelsea Clair and Kyle Froelich met at a 2009 car show when he was … |